[Cancer immunotherapy: an update]

Area of Science:

• Oncology
• Immunology
• Cancer Therapeutics

Background:

• Cancer remains a leading global cause of death, with conventional therapies like chemotherapy facing limitations due to toxicity and resistance.
• Targeted therapies also encounter challenges with induced resistance in various malignancies.
• The need for more effective and specific cancer treatments is critical.

Purpose of the Study:

• To explore immunotherapy as a superior approach for cancer treatment by enhancing the immune system's ability to recognize and eliminate cancer cells.
• To highlight the role of acquired immunity and antigen-specific T cells in novel immunotherapeutic strategies.
• To discuss the advantages of immunotherapy, including the generation of long-term immunological memory.

Main Methods:

• Review of current immunotherapeutic strategies for cancer.
• Analysis of mechanisms involving innate and acquired immunity in cancer recognition.
• Examination of T cell-mediated immune responses against cancer antigens.

Main Results:

• Immunotherapy utilizes the immune system to distinguish cancer cells from healthy cells.
• Antigen-specific T cells are a key component of effective immunotherapy.
• Various immunotherapy types, including cytokines, vaccines, viruses, monoclonal antibodies, and adoptive cell transfer, show promise.

Conclusions:

• Immunotherapy represents a significant advancement over traditional cancer treatments.
• Harnessing acquired immunity and T cell responses offers a powerful strategy for cancer elimination.
• The development of diverse immunotherapeutic approaches holds potential for improved patient outcomes and long-term cancer immunity.